SCHEMBL4386770

SCHEMBL4386770

COCCc1c(C(=O)OC)c(OCOC)cc(OCOC)c1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
EGFR P00533 3/20 0.41
TP53 P04637 2/20 0.40
AR P10275 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 1/20 0.38
RAB9A P51151 1/20 0.38
CHEK1 O14757 1/20 0.37
AURKA O14965 1/20 0.37
DAPK3 O43293 1/20 0.37
JAK2 O60674 1/20 0.37
ABL1 P00519 1/20 0.37
NTRK1 P04629 1/20 0.37
FYN P06241 1/20 0.37
CSF1R P07333 1/20 0.37
RET P07949 1/20 0.37
IGF1R P08069 1/20 0.37
MET P08581 1/20 0.37
PDGFRB P09619 1/20 0.37
PIM1 P11309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4381558 0.90 EGFR (0.45) EGFRTP53SMN1; SMN2KDM4EL3MBTL1
SCHEMBL4384151 0.89 EGFR (0.42) LMNAEGFRTP53SMN1; SMN2ALDH1A1
SCHEMBL2867378 0.88 EGFR (0.44) LMNAEGFRTP53KDM4EL3MBTL1
SCHEMBL4384182 0.87 EGFR (0.40) LMNAEGFRTP53SMN1; SMN2ALDH1A1
SCHEMBL4395195 0.86 EGFR (0.40) EGFRTP53SMN1; SMN2KDM4EL3MBTL1
SCHEMBL4388307 0.85 EGFR (0.39) EGFRTP53SMN1; SMN2KDM4EL3MBTL1
SCHEMBL4386937 0.84 EGFR (0.40) LMNAEGFRTP53SMN1; SMN2ALDH1A1
SCHEMBL4381699 0.83 EGFR (0.44) EGFRTP53ALDH1A1KDM4EMEN1
SCHEMBL4392560 0.82 CREBBP (0.39) EGFRCHEK1AURKADAPK3JAK2
SCHEMBL4384178 0.82 EGFR (0.42) EGFRTP53SMN1; SMN2KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P LMNA 4706/4885EGFR 624/4885TP53 918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.